Lyp/PTPN22 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-81276
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against Recombinant Protein corresponding to amino acids: SLLNQESAVLATAPRIDDEIPPPLPVRTPESFIVVEEAGEFSPNVPKSLSSAVKVKIGTSLEWGGTSEPKKFDDSVILRPSKSVKLRSPKSELHQDRSSPPPPLPERTLESFFLADEDCMQ
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Lyp/PTPN22 Antibody
Immunohistochemistry-Paraffin: Lyp/PTPN22 Antibody [NBP1-81276]
Immunohistochemistry-Paraffin: Lyp/PTPN22 Antibody [NBP1-81276] - Staining of human bone marrow shows strong cytoplasmic positivity in hematopoietic cells.Applications for Lyp/PTPN22 Antibody
Application
Recommended Usage
Immunohistochemistry
1:20 - 1:50
Immunohistochemistry-Paraffin
1:20 - 1:50
Application Notes
HIER pH6 retrieval is recommended.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Lyp
Long Name
Lymphoid Phosphatase
Alternate Names
LyPTP, PEP, PTPN22, PTPN8 (former)
Gene Symbol
PTPN22
Additional Lyp Products
Product Documents for Lyp/PTPN22 Antibody
Product Specific Notices for Lyp/PTPN22 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...